EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unveiling Metabolic Subtypes in Endometrial Cancer Cell Lines: Insights from Metabolomic Analysis Under Standard and Stress Conditions

Lana McCaslin, Simon Lagies iD, Daniel A Mohl iD, Dietmar A Plattner, Markus Jäger, Claudia Nöthling, Matthias C Huber, Ingolf Juhasz-Böss iD, Bernd Kammerer, Clara Backhaus iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26199573 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Lana McCaslin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Core Competence Metabolomics, Hilde-Mangold-Haus, University of Freiburg, 79104 Freiburg, Germany. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Metabolomics, Metabolome, Stress, Physiological. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Internal Medicine II, Medical Center—University of Freiburg and Medical Faculty.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometrial carcinoma (EC) is the most common malignancy of the female reproductive tract, with increasing incidence driven by aging populations and obesity. While molecular classification has improved diagnostic precision, the identification of clinically relevant metabolic biomarkers remains incomplete, and targeted therapies are not yet standardized. In this study, we investigated metabolic alterations in four EC cell lines (AN3-CA, EFE-184, HEC-1B and MFE-296) compared to non-malignant controls under normoxic and stress conditions (hypoxia and lactic acidosis) to identify metabolomic differences with potential clinical relevance. Untargeted gas chromatography–mass spectrometry (GC/MS) and targeted liquid chromatography–mass spectrometry (LC/MS) profiling revealed two distinct metabolic subtypes of EC. Cells of metabolic subtype 1 (AN3-CA and EFE-184) exhibited high biosynthetic and energy demands, enhanced cholesterol and hexosyl-ceramides synthesis and increased RNA stability, consistent with classical cancer-associated metabolic reprogramming. Cells of metabolic subtype 2 (HEC-1B and MFE-296) displayed a phospholipid-dominant metabolic profile and greater hypoxia tolerance, suggesting enhanced tumor aggressiveness and metastatic potential. Key metabolic findings were validated via real-time quantitative PCR. This study identifies and characterizes distinct metabolic subtypes of EC within the investigated cancer cell lines, thereby contributing to a better understanding of tumor heterogeneity. The results provide a basis for potential diagnostic differentiation based on specific metabolic profiles and may support the identification of novel therapeutic targets. Further validation in three-dimensional culture models and ultimately patient-derived samples is required to assess clinical relevance and integration with current molecular classifications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsMetabolomicsMetabolomeStress, PhysiologicalHumansFemaleCell Line, TumorGas Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

GC/MSLC/MScancer metabolismendometrial cancerhypoxialactic acidosismass spectrometrymetabolic profilingmetabolic subtypes

Autor:innen und Institutionen

  • Core Competence Metabolomics, Hilde-Mangold-Haus, University of Freiburg, 79104 Freiburg, Germany.
  • Department of Obstetrics & Gynecology, Medical Center and Faculty of Medicine-University of Freiburg, Hugstetter Str. 55, 79106 Freiburg, Germany.
  • Institute of Organic Chemistry, University of Freiburg, 79104 Freiburg, Germany.
  • Signaling Research Centre BIOSS, University of Freiburg, 79104 Freiburg, Germany.
  • Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg, 79104 Freiburg, Germany.

ORCID-Profile: Simon Lagies, Daniel A Mohl, Ingolf Juhasz-Böss, Clara Backhaus

Förderung

  • Deutsche Forschungsgemeinschaft
  • Internal Medicine II, Medical Center—University of Freiburg and Medical Faculty

Zitieren

APA

McCaslin, L., Lagies, S., Mohl, D. A., Plattner, D. A., Jäger, M., Nöthling, C., Huber, M. C., Juhasz-Böss, I., Kammerer, B., & Backhaus, C. (2025). Unveiling Metabolic Subtypes in Endometrial Cancer Cell Lines: Insights from Metabolomic Analysis Under Standard and Stress Conditions. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199573

Vancouver

McCaslin L, Lagies S, Mohl DA, Plattner DA, Jäger M, Nöthling C, et al. Unveiling Metabolic Subtypes in Endometrial Cancer Cell Lines: Insights from Metabolomic Analysis Under Standard and Stress Conditions. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199573

BibTeX
@article{McCaslin2025,
  author = {McCaslin, Lana and Lagies, Simon and Mohl, Daniel A and Plattner, Dietmar A and Jäger, Markus and Nöthling, Claudia and Huber, Matthias C and Juhasz-Böss, Ingolf and Kammerer, Bernd and Backhaus, Clara},
  title = {Unveiling Metabolic Subtypes in Endometrial Cancer Cell Lines: Insights from Metabolomic Analysis Under Standard and Stress Conditions},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26199573}
}
Kostenlos starten →